GoodRx Holdings (GDRX) Other Operating Expenses (2019 - 2026)

GoodRx Holdings' Other Operating Expenses history runs 8 years deep, the most recent figure standing at $123.0 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 3.52% year-over-year to $123.0 million; the TTM figure through Mar 2026 stood at $478.6 million (down 1.39% YoY), while the FY2025 annual figure was $470.2 million, down 2.12% from the prior year.
• Other Operating Expenses came in at $123.0 million for Q1 2026 at GoodRx Holdings, up from $119.2 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $152.5 million in Q4 2023 to a low of -$41.7 million in Q3 2022.
• A 5-year average of $91.6 million and a median of $118.4 million in 2025 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses slumped 110.1% in 2022 and jumped 7834.74% in 2023, its largest moves.
• GoodRx Holdings' Other Operating Expenses stood at -$2.0 million in 2022, then surged by 7834.74% to $152.5 million in 2023, then slipped by 17.97% to $125.1 million in 2024, then dropped by 4.71% to $119.2 million in 2025, then rose by 3.17% to $123.0 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $123.0 million, $119.2 million, and $118.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison